¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦42Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ (2ÀÏÂ÷) : 2023-06-24

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦42Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ (2ÀÏÂ÷) : 2023-06-24
±³À°ÀÏÀÚ : 2023-06-24
±³À°Àå¼Ò : ºÎ»ê BEXCO ÄÁº¥¼ÇȦ 1F, 2F

±³À°ÁÖÁ¦ : ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦42Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ (2ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ
´ã´çÀÚ : Á¶¿¹¸®
¿¬¶ôó : 02-582-8222  

À̸ÞÀÏ : yehc@kscvi.org

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 800¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 19 ½Ã°£ 17ºÐ

¼¼ºÎ¼ö°­·á : 120,000¿ø  

ºñ°í - Àü¹®ÀÇ,°³¿øÀÇ,ÀϹÝÀÇ:(ÇöÀåµî·Ï)60,000¿ø - ÀüÀÓÀÇ,Àü°øÀÇ,°£È£»ç,ÀÇ·á±â»ç,ÀÇ´ë»ý,±ºÀÇ°ü,°øÁߺ¸°ÇÀÇ,ÀÓ»óº´¸®»ç,Àǹ«±â·Ï»ç:(ÇöÀåµî·Ï)50,000¿ø - »ê¾÷ü,±âŸ:(ÇöÀåµî·Ï)120,000¿ø - ÇÐȸ Á¤È¸¿ø(Àü³âµµ ȸºñ¿Ï³³ÀÚ): ¹«·á


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 24ÀÏ Main Arena 09:00~09:30 ´©±¸³ª NEJM(The New England Journal of Medicine) ³¾ ¼ö ÀÖ´Ù: RCT(Randomized Controlled Trials) ¿¬±¸Åë°è½ÇÀü Çٽɿä¾à, NEJMÀÇ ¿ä±¸»çÇ×°ú ´ëÀÀ¹æ¾È °­´Üºñ(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 24ÀÏ Main Arena 09:30~10:00 °ÆÁ¤ ¾ø´Â ¡°Non-Inferiority Trial¡±: Non-Inferiority ¿¬±¸ ½ÃÀÛºÎÅÍ ¸¶¹«¸®±îÁö ½ÇÀü ÃÖÀûÈ­ ÈÆ·Ã ±èÁø¼·(Â÷¶óÅõ ÁÖ½Äȸ»ç)

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 09:00~09:12 (Ãʷϱ¸¿¬¹ßÇ¥) JCI(Journal of Cardiovascular Intervention), the Beginning and Roadmap to SCI È«¿µÁØ(Àü³²ÀÇ´ë)

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 09:12~09:24 (Ãʷϱ¸¿¬¹ßÇ¥) KCJ(Korean Circulation Journal): Success Story of KCJ and Advice to JCI(Journal of Cardiovascular Intervention) äÀÎÈ£(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 09:24~09:36 (Ãʷϱ¸¿¬¹ßÇ¥) JLA(Journal of Lipid and Atherosclerosis): Trip to SCOPUS, How Did We Get To? °­Çö(Áß¾ÓÀÇ´ë)

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 09:36~09:48 (Ãʷϱ¸¿¬¹ßÇ¥) How to Improve the Quality of JCI(Journal of Cardiovascular Intervention) for PMC Application Çã¼±(ÇѸ²ÀÇ´ë)

Åä·Ð 06¿ù 24ÀÏ Symposium Arena 09:48~10:00 Discussion ()

ÈÞ½Ä 06¿ù 24ÀÏ 10:00~10:05 Break ()

±³À°½Ã°£ 06¿ù 24ÀÏ Main Arena 10:05~10:15 (Ãʷϱ¸¿¬¹ßÇ¥) AMI(Acute Myocardial Infarction) with Multivessel Stenosis Á¤¿µÈÆ(Áß¾ÓÀÇ´ë)

±³À°½Ã°£ 06¿ù 24ÀÏ Main Arena 10:15~10:25 (Ãʷϱ¸¿¬¹ßÇ¥) AMI(Acute Myocardial Infarction) of Unusual Cause À±¿ëÈÆ(Ãæ³²ÀÇ´ë)

±³À°½Ã°£ 06¿ù 24ÀÏ Main Arena 10:25~10:35 (Ãʷϱ¸¿¬¹ßÇ¥) AMI(Acute Myocardial Infarction) with Acute Ischemic or Hemorrhagic Stroke Çã¾Ö¿µ(°­¿øÀÇ´ë)

±³À°½Ã°£ 06¿ù 24ÀÏ Main Arena 10:35~10:45 (Ãʷϱ¸¿¬¹ßÇ¥) AMI(Acute Myocardial Infarction) with Significant Bleeding ÀÓ¿µÈ¿(ÇѾçÀÇ´ë)

Åä·Ð 06¿ù 24ÀÏ Main Arena 10:45~11:05 Discussion ()

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 10:05~10:15 (Ãʷϱ¸¿¬¹ßÇ¥) Intraluminal versus Subintimal Wiring for Long F-P(Fibropapillomatosis) CTO(Chronic Total Occlusion) ±Ç¿À¼º(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 10:15~10:25 (Ãʷϱ¸¿¬¹ßÇ¥) Angio-guided versus IVUS(Intravascular Ultrasonography)-guided Procedures ÁøÇÑ¿µ(ÀÎÁ¦ÀÇ´ë)

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 10:25~10:35 (Ãʷϱ¸¿¬¹ßÇ¥) Atherectomy & Thrombectomy Devices in F-P(Fibropapillomatosis) Disease ÀÌÁßÈñ(¿¬¼¼¿øÁÖÀÇ´ë)

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 10:35~10:45 (Ãʷϱ¸¿¬¹ßÇ¥) DCB(Drug-coated Balloon) versus DES(Drug-eluting Stent) for Long Term Patency ÇÑÁ¤±Ô(¼­¿ïÀÇ´ë)

ÈÞ½Ä 06¿ù 24ÀÏ Symposium Arena 10:45~11:05 Discussion ()

±³À°½Ã°£ 06¿ù 24ÀÏ Seminar Room 10:05~10:20 (Ãʷϱ¸¿¬¹ßÇ¥) How to Treat Culprit Lesion? - What Should Do and What Should Not Do? Á¤Áø(°¡Å縯ÀÇ´ë ¼ººó¼¾Æ®º´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ Seminar Room 10:20~10:35 (Ãʷϱ¸¿¬¹ßÇ¥) How to Treat Non-culprit Lesion? - Review of Recent Trials ±Ç¿ìÂù(¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ Seminar Room 10:35~10:50 (Ãʷϱ¸¿¬¹ßÇ¥) Post-interventional Management - Review of GDMT(Guideline-directed medical therapy) from Guidelines ÀÌÁøÈ£(¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø)

Åä·Ð 06¿ù 24ÀÏ Seminar Room 10:50~11:05 Discussion ()

ÈÞ½Ä 06¿ù 24ÀÏ 11:05~11:10 Break ()

±âŸ 06¿ù 24ÀÏ Main Arena 11:10~11:30 ÁßÀç½Ã¼úÀÇ·áÀÎÀ¸·Î »ì¾Æ³²±â: "¼Õ½¬¿î ±Ù°ñ°Ý°è °ü¸® ¼Ö·ç¼Ç" ÀÌÁøÇõ(°í·ÁÀÇ´ë)

±âŸ 06¿ù 24ÀÏ Main Arena 11:30~11:50 ÁßÀç½Ã¼úÀÇ·áÀÎÀÇ °Ç°­ °ü¸®: "Cathlab°ú Ç㸮 °Ç°­" ³²±â¼¼(³²±â¼¼º´¿ø)

±âŸ 06¿ù 24ÀÏ Main Arena 11:50~12:10 ÁßÀç½Ã¼úÀÇ·áÀÎÀÇ Ã¼·Â/Áö±¸·Â/´ÙÀ̾îÆ®¸¦ À§ÇÑ ÅäÅ»¿îµ¿: "Áܹ٠ÇÇÆ®´Ï½º" Á¶Á¤·¡(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 11:10~11:25 TAVI(Trans-catheter Aortic Valve Implantation) ½É»ç±âÁØÀÇ ÀÓ»óÀû¿ë°ú ½ÇÁ¦ °­ÁöÈÆ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 11:25~11:40 TAVI(Trans-catheter Aortic Valve Implantation)°¡ ³ª¾Æ°¡¾ß ÇÒ ¹æÇâ Á¶¿µ´ë(º¸°Çº¹ÁöºÎ º¸Çè±Þ¿©°ú)

Åä·Ð 06¿ù 24ÀÏ Symposium Arena 11:40~12:10 Discussion ()

±³À°½Ã°£ 06¿ù 24ÀÏ Seminar Room 11:10~11:30 Better Anticoagulation Management for Afib Patients with ACS(Acute Coronary Syndrome)/PCI(Percutaneous Coronary Intervention) À̽ÂÁØ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 24ÀÏ Seminar Room 11:30~11:50 Atrial Fibrillation and Anticoagulation: Deep Dive into the Recent RWE ¹Ú°æ¿ì(¼­¿ïÀÇ´ë)

Åä·Ð 06¿ù 24ÀÏ Seminar Room 11:50~12:10 Discussion ()

ÈÞ½Ä 06¿ù 24ÀÏ 12:10~12:15 Break ()

±âŸ 06¿ù 24ÀÏ Main Arena 12:15~12:20 Opening Remark ()

±³À°½Ã°£ 06¿ù 24ÀÏ Main Arena 12:20~12:40 Prevail Case Sharing: All Right Let °­µ¿¿À(°í·ÁÀÇ´ë)

±³À°½Ã°£ 06¿ù 24ÀÏ Main Arena 12:40~13:00 Resolute Onyx Case Sharing Àå¿ìÁø(ÀÌÈ­ÀÇ´ë)

Åä·Ð 06¿ù 24ÀÏ Main Arena 13:00~13:15 Discussion ()

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 12:15~12:35 From Good to Great: How Prasugrel Is Enhancing ACS-PCI(Acute Coronary Syndrome-Percutaneous Coronary Intervention) Outcomes ±èÇö±¹(Á¶¼±ÀÇ´ë)

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 12:35~12:55 Anticoagulation Strategy in AF Patients Undergoing PCI(Percutaneous Coronary Intervention) or TAVR(Transcatheter Aortic Valve Replacement) °­µµÀ±(¿ï»êÀÇ´ë)

Åä·Ð 06¿ù 24ÀÏ Symposium Arena 12:55~13:15 Discussion ()

±âŸ 06¿ù 24ÀÏ Seminar Room 12:15~12:20 Opening Remark ()

±³À°½Ã°£ 06¿ù 24ÀÏ Seminar Room 12:20~12:40 IVUS(Intravascular Ultrasonography) 123 Essentials - What You Should Know to Optimize PCI(Percutaneous Coronary Intervention) À±ÇõÁØ(°è¸íÀÇ´ë)

±³À°½Ã°£ 06¿ù 24ÀÏ Seminar Room 12:40~13:00 IVUS(Intravascular Ultrasonography) 123 in Action - What Makes to Overcome CHIP(High Risk Percutaneous Coronary Intervention) with IVUS(Intravascular Ultrasonography) ÃßÀºÈ£(°¡Å縯ÀÇ´ë)

Åä·Ð 06¿ù 24ÀÏ Seminar Room 13:00~13:15 Discussion ()

±âŸ 06¿ù 24ÀÏ Main Arena 13:15~13:30 ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ ȸÀå ÀÌÃëÀÓ½Ä ()

±³À°½Ã°£ 06¿ù 24ÀÏ Main Arena 13:30~13:40 (Ãʷϱ¸¿¬¹ßÇ¥) When PCI Meets FFR(Fractional Flow Reserve) ³²Ã¢¿í(°è¸íÀÇ´ë)

±³À°½Ã°£ 06¿ù 24ÀÏ Main Arena 13:40~13:50 (Ãʷϱ¸¿¬¹ßÇ¥) When PCI Meets IVUS(Intravascular Ultrasonography) ±èº´±Ø(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 24ÀÏ Main Arena 13:50~14:00 (Ãʷϱ¸¿¬¹ßÇ¥) When PCI Meets iFR(Instantaneous Flow Ratio) Shoichi Kuramitsu(Sapporo Cardio Vascular Clinic. Japan)

±³À°½Ã°£ 06¿ù 24ÀÏ Main Arena 14:00~14:10 (Ãʷϱ¸¿¬¹ßÇ¥) When PCI Meets OCT(Optical Coherence Tomography) Maoto Habara(Toyohashi Heart Center. Japan)

Åä·Ð 06¿ù 24ÀÏ Main Arena 14:10~14:30 Discussion ()

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 13:30~13:45 (Ãʷϱ¸¿¬¹ßÇ¥) What Do I Do as a Cardiologist in USA ÀÌÁÖ¿ë(University of Connecticut. USA)

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 13:45~14:00 (Ãʷϱ¸¿¬¹ßÇ¥) How to I Do Study as a Medical Clinic Doctor Á¤ÇÑ»ù(Á¤ÇÑ»ù³»°ú)

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 14:00~14:15 (Ãʷϱ¸¿¬¹ßÇ¥) How to I Do RCT outside of the Big Medical Center Á¤ÀçÇå(³²¾çÁÖÇѾ纴¿ø)

Åä·Ð 06¿ù 24ÀÏ Symposium Arena 14:15~14:30 Discussion ()

±âŸ 06¿ù 24ÀÏ Seminar Room 13:30~13:33 Session introduction ()

±³À°½Ã°£ 06¿ù 24ÀÏ Seminar Room 13:33~13:48 (Ãʷϱ¸¿¬¹ßÇ¥) Hostile Anatomy - Overcome Accessing ÃÖ¶ô°æ(ÀÎõ¼¼Á¾º´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ Seminar Room 13:48~14:03 (Ãʷϱ¸¿¬¹ßÇ¥) Hostile Anatomy - Overcome Valvular Heavy Calcification ¾ÈÁ¤¹Î(¿ï»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 24ÀÏ Seminar Room 14:03~14:18 (Ãʷϱ¸¿¬¹ßÇ¥) Hostile Anatomy - Overcome Non-valvular Hurdle ¹ÚÇÏ¿í(ºÎõ¼¼Á¾º´¿ø)

Åä·Ð 06¿ù 24ÀÏ Seminar Room 14:18~14:30 Discussion ()

ÈÞ½Ä 06¿ù 24ÀÏ 14:30~14:35 Break ()

±³À°½Ã°£ 06¿ù 24ÀÏ Main Arena 14:35~14:45 (Ãʷϱ¸¿¬¹ßÇ¥) Heart‐Brain Team Approach of Acute Myocardial Infarction Complicating Acute Stroke - Cardiology Perspective ¹Ú»óµ·(ÀÎÇÏÀÇ´ë)

±³À°½Ã°£ 06¿ù 24ÀÏ Main Arena 14:45~14:55 (Ãʷϱ¸¿¬¹ßÇ¥) Heart‐Brain Team Approach of Acute Myocardial Infarction Complicating Acute Stroke - Neurology Perspective Â÷Àç°ü(µ¿¾ÆÀÇ´ë)

±³À°½Ã°£ 06¿ù 24ÀÏ Main Arena 14:55~15:05 (Ãʷϱ¸¿¬¹ßÇ¥) Heart-Brain Team Management for Ischemic Stroke - Cardiology Perspective À±Ã¢È¯(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 24ÀÏ Main Arena 15:05~15:15 (Ãʷϱ¸¿¬¹ßÇ¥) Heart-Brain Team Management for Ischemic Stroke - Neurology Perspective ±èÁØÅÂ(Àü³²ÀÇ´ë)

Åä·Ð 06¿ù 24ÀÏ Main Arena 15:15~15:35 Discussion ()

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 14:35~14:45 (Ãʷϱ¸¿¬¹ßÇ¥) M-TEER(Transcatheter Edge-to-Edge Mitral Valve Repair) Update in Mitral Regurgitation ±èÁß¼±(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 14:45~14:55 (Ãʷϱ¸¿¬¹ßÇ¥) Functional MS(Multiple Sclerosis): Means, Diagnosis and Treatment ±èÀº°æ(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 14:55~15:05 (Ãʷϱ¸¿¬¹ßÇ¥) TMVR: Is It Future Treatment of Mitral Valve Disease? ÀÌöÇö(°è¸íÀÇ´ë)

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 15:05~15:15 (Ãʷϱ¸¿¬¹ßÇ¥) Current Situation of T-TEER(Transcatheter Edge to Edge Repair) °­µµÀ±(¿ï»êÀÇ´ë)

Åä·Ð 06¿ù 24ÀÏ Symposium Arena 15:15~15:35 Discussion ()

±³À°½Ã°£ 06¿ù 24ÀÏ Seminar Room 14:35~14:50 (Ãʷϱ¸¿¬¹ßÇ¥) How to Diagnose Ischemic Cardiomyopathy? ±Ç¿ìÂù(¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ Seminar Room 14:50~15:05 (Ãʷϱ¸¿¬¹ßÇ¥) How to Optimize GDMT(Guideline-directed medical therapy) in Ischemic Cardiomyopathy? - Review of GDMT from Guidelines ±èÈ£¿¬(¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ Seminar Room 15:05~15:20 (Ãʷϱ¸¿¬¹ßÇ¥) How to Apply Interventional Treatment to Ischemia Cardiomyopathy? - From Coronary Intervention to Device Therapy À̱âȯ(¼­¿ï´ëÇб³º´¿ø)

Åä·Ð 06¿ù 24ÀÏ Seminar Room 15:20~15:35 Discussion ()

ÈÞ½Ä 06¿ù 24ÀÏ 15:35~15:40 Break ()

±³À°½Ã°£ 06¿ù 24ÀÏ Main Arena 15:40~15:52 (Ãʷϱ¸¿¬¹ßÇ¥) Early invasive percutaneous coronary intervention on myocardial ischemia caused by coronary artery compression by perivalvular abscesses: A case report Á¤Áø¾Æ(°æºÏ´ëÇб³º´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ Main Arena 15:52~16:04 (Ãʷϱ¸¿¬¹ßÇ¥) Novel strategy for retrieving a kinked catheter: An unknown usage of Forceps ±è»óÈ¿(ÀüºÏ´ëÇб³º´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ Main Arena 16:04~16:16 (Ãʷϱ¸¿¬¹ßÇ¥) Intravascular ultrasonography catheter stuck during percutaneous coronary intervention ÃÖ¿¬¿ì(¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ Main Arena 16:16~16:28 (Ãʷϱ¸¿¬¹ßÇ¥) A case of re-trial of multiple CTO(Chronic Total Occlusion) : Application of hybrid approach strategy ±èÁß¹Î(¿¬¼¼ÀÇ´ë ½ÉÀåÇ÷°üº´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ Main Arena 16:28~16:40 (Ãʷϱ¸¿¬¹ßÇ¥) Challenges of Spilled Lipid Materials and White Thrombi During Percutaneous Coronary Intervention ¹Ú°æÅÃ(Áß¾Ó´ëÇб³º´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 15:40~15:50 (Ãʷϱ¸¿¬¹ßÇ¥) Angiography Guided PCI(Percutaneous Coronary Intervention)? ÀÓµµÇü(ÀÎõ¼º¸ðº´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 15:50~16:00 (Ãʷϱ¸¿¬¹ßÇ¥) Physiology Guided PCI(Percutaneous Coronary Intervention)? Áø¿µÈÆ(Àü³²´ëÇб³º´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 16:00~16:10 Discussion ()

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 16:20~16:20 (Ãʷϱ¸¿¬¹ßÇ¥) What Do You Think of Adenosine? ±è¼±¹è(¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 16:20~16:30 (Ãʷϱ¸¿¬¹ßÇ¥) What Do You Think of Nicorandil? ±èÈ¿¿ø(»ï¼º¼­¿ïº´¿ø)

Åä·Ð 06¿ù 24ÀÏ Symposium Arena 16:30~16:40 Discussion ()

ÈÞ½Ä 06¿ù 24ÀÏ 16:40~16:45 Break ()

±³À°½Ã°£ 06¿ù 24ÀÏ Main Arena 16:45~16:57 (Ãʷϱ¸¿¬¹ßÇ¥) Percutaneous Closure of Paravalvular Leak from a Rocking Mitral Valve in a 66-Year-Old Woman at High Surgical Risk ÀÌÈñÁø(¼­¿ï´ëÇб³º´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ Main Arena 16:57~17:09 (Ãʷϱ¸¿¬¹ßÇ¥) Cardiac arrest due to migration of initial self-expandable aortic valve followed by successful return of spontaneous circulation after second valve implantation ÃÖ¼ºÈ¯(ÀÎÇÏ´ëÇб³º´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ Main Arena 17:09~17:21 (Ãʷϱ¸¿¬¹ßÇ¥) Trans aortic valve implantation (TAVI) in a patient with severe aortic stenosis who had undergone comprehensive aortic root and valve repair (CARVAR) ÀÓ¼Ò¹Î(¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ Main Arena 17:21~17:33 (Ãʷϱ¸¿¬¹ßÇ¥) Successful TAVI(Trans aortic valve implantation) after a severe underexpansion of ACURATE Neo2 valve ÀÓ¼öºó(°í·Á´ëÇб³ ¾È¾Ïº´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ Main Arena 17:33~17:45 (Ãʷϱ¸¿¬¹ßÇ¥) A case of Complication with Mynx control hemostasis device after successful PTA(Percutaneous transluminal angioplasty) ÃÖ¿¬Á÷(°¡Å縯ÀÇ´ë ÀºÆò¼º¸ðº´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 16:45~16:55 (Ãʷϱ¸¿¬¹ßÇ¥) Balloon-expandable Valve Is Better! ¼Û°É¼ö(ºÐ´ç¼­¿ï´ëÇб³º´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 16:55~17:05 (Ãʷϱ¸¿¬¹ßÇ¥) Self-expandable Valve Is Better! ÀÌÇÏÁØ(±³·Á´ëÇб³ ¾È¾Ïº´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 17:05~17:15 Discussion ()

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 17:15~17:25 (Ãʷϱ¸¿¬¹ßÇ¥) Use of DCB(Drug-coated Balloon) in Small Vessel Disease ¼­¿õ(°í·Á´ëÇб³ ±¸·Îº´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ Symposium Arena 17:25~17:35 (Ãʷϱ¸¿¬¹ßÇ¥) Use of Stent in Small Vessel Disease Á¶¹ÎÁØ(ÃæºÏ´ëÇб³º´¿ø)

Åä·Ð 06¿ù 24ÀÏ Symposium Arena 17:35~17:45 Discussion ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦42Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ (2ÀÏÂ÷) : 2023-06-24""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑ°¡Á¤ÀÇÇÐȸ ÀÎõÁöȸ ¿¬¼ö±³À° -ÀÏÂ÷Áø·áÀÇ ÃÖ½ÅÁö°ß : 2023-06-24
´ÙÀ½±Û °£Áú¼ºÆóÁúȯ(ILD)¿¬±¸È¸ ILD School 2023 : 2023-06-24
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 29 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 28 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 33 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 38 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 30 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 22 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 8 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 9 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 18 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 12 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 8 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 23 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 13 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 21 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 16 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷